Advertisement

Related Videos

Leonard B. Saltz, MD, on the Future of Interventional Pharmacoeconomics

Peter Clark, MA, MD, FRCP: A Payer Perspective

Cody Peer, PhD, on Simulating Alternative Schedules for Checkpoint Inhibitors

Ian Tannock, MD, PhD, DSc, on Near-Equivalence: A Better Question Than Non-Inferiority

Robin Feldman, JD: Are Dubious Patents a Large or Small Issue?

Advertisement

Advertisement




Mar
24
Today In Oncology
Study Finds Inferior Survival Among Black Patients With AML, Independent of Cytogenetic Risk
Lisocabtagene Maraleucel in Relapsed or Refractory MZL
Dietary Influence on Leukemia and Lymphoma Progression
Three AI-Enabled Analyses Highlight Context-Dependent Biomarkers in Early-Onset Colorectal Cancer
Small Phase II Study Examines Triplet Regimen for Patients With HER2-Positive Breast Cancer and Leptomeningeal Metastasis
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo